Kazia Therapeutics Limited (KZIA)

NASDAQ: KZIA · Real-Time Price · USD

8.11

-0.41 (-4.81%)

At close: Mar 11, 2026, 4:00 PM EDT

8.10

-0.01 (-0.12%)

After-hours: Mar 11, 2026, 5:03 PM EDT

Kazia Therapeutics Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Net Income	-20.7	-26.78	-20.47
Depreciation & Amortization	0.93	1.87	1.87
Stock-Based Compensation	0.65	0.53	1.16
Other Adjustments	8.85	4.79	-2.05
Change in Receivables	3.8	0.01	3.45
Changes in Accounts Payable	-4.95	10.74	0.57
Changes in Other Operating Activities	-1.86	-0.74	0.31
Operating Cash Flow	-13.28	-9.58	-15.16
Issuance of Common Stock	15.98	5.58	12.97
Net Common Stock Issued (Repurchased)	15.98	5.58	12.97
Other Financing Activities	-	0.41	-
Financing Cash Flow	15.98	5.99	12.97
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.02	0.01	0.06
Net Cash Flow	2.7	-3.6	-2.18
Free Cash Flow	-13.28	-9.58	-15.16
FCF Margin	-725.97%	-386.17%	-1515600.00%
Free Cash Flow Per Share	-12.12	-18.17	-41.12
Levered Free Cash Flow	-26.58	-14.91	-17.71
Unlevered Free Cash Flow	-31.32	-16.31	-21.08

Updated Nov 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q